Agenda
2008 HBS Health Industry Alumni Conference
Thursday, November 6
Friday, November 7
Saturday, November 8
New Post-Conference Event
Unleashing Harvard Innovations: A showcase of Harvard University's top medical technology spin out companies
Saturday, November 8
Open to all, free to Conference attendees — Register separately
Click for details
|
Thursday, November 6 _________________________________________________________________ |
5:30 PM - 9:00 PM |
Badge Pick-Up (No onsite registration.) |
6:00 PM - 8:30 PM |
Champagne Reception
|
Friday, November 7 |
|
7:30 AM - 6:30 PM |
Badge Pick-Up (No onsite registration.) |
| 7:30 - 8:30 AM Ground Floor Lobby outside Amphitheater |
Continental Breakfast |
8:30 - 9:00 AM |
Healthcare at the Intersection of Medicine, Technology and Business
|
| 9:00 - 9:45 AM Amphitheater |
Convergence of Engineering and Biology at MIT
The past decades have produced many advances in the understanding of the molecular and cellular nature of diseases including cancer. One of these advances is the recognition of the importance of small RNAs in biological systems. The convergence of the science of molecular and cellular biology with engineering promises to both accelerate discovery as well as translate this discovery to medical care. |
| 9:45 - 10:15 AM Ground Floor Lobby |
Coffee Break/Networking |
| 10:15 - 11:00 AM Amphitheater |
The Coming Collision: How Information Technology and Restless Consumers Will Wrest Health Care’s Future From Policymakers and Professionals
Advances in information technology and shifting consumer preferences are driving fundamental changes in the way health care is organized, financed and delivered. Consumers are becoming more aware of their health, well-informed about their choices and options and shopping for the best care at the lowest prices. As a result, health care progress may not unfold in the ways called for in numerous white papers, commission reports and policy proposals. It may instead disrupt existing organizations and brands, shift market power and alter longstanding assumptions and practices among professionals, policymakers and other traditional health care overseers. |
11:00 AM - 11:45 PM |
The Business of Genomics: A Look Back and A Look Forward
Tony White spent more than 25 years rising through the ranks at Baxter International and developing and selling products that monitored or managed, as much as possible, the symptoms of illness. He became CEO of Norwalk, CT-based Perkin Elmer in 1995, seeing the developing opportunity to apply the DNA analysis technologies of its Applied Biosystems unit to study—and perhaps eventually to treat—the root causes of disease. White’s talk will recount the high and low points of the business of genomics over the past 13 years. He'll take us from the heady days of supplying the Human Genome Project and creating Celera, challenger to the scientific establishment served by Applied Biosystems, to the lean years after the genomics bubble burst and NIH spending stalled. Then he will bring us to the present and beyond, when new tools for structural and functional biology are powering a more sophisticated understanding of gene regulation and genetic diversity, and when content developers like Celera are introducing molecular diagnostic tests for heart disease and cancer and other conditions—genetic tests that begin to validate the promise of the genomic revolution. |
| 12:00 - 1:00 PM Rotunda |
Luncheon |
| 1:00 - 1:45 PM Amphitheater |
What goes over the line? How Government Promotes and Regulates Personalized Medicine
Assistant Secretary Sasse will give an overview of government activities surrounding the promotion and regulation of personalized medicine, and a synopsis of the Genetic Information Nondiscrimination Act signed into law in May. He will outline HHS's efforts to build a strong foundation for personalized health care established in the Secretary’s Personalized Health Care Initiative, intended to improve the safety, quality and effectiveness of healthcare. He’ll discuss the work HHS has initiated across agencies addressing complex issues to ensure that new information and capabilities will be used appropriately. The government will provide federal leadership supporting research into specific aspects of disease and disease prevention with the goal of shaping preventive and diagnostic care to match each person’s unique genetic characteristics. |
1:45 - 4:15 PM |
The Promise and Pitfalls of Personal Genomics and Personalized Medicine Presentations and Panel Speakers and a panel discussion will delve into both the wide-open potential and possible pitfalls of these burgeoning fields. While it cost $3 billion to sequence the first human genome, several companies now will sequence key genes for $1000. For $350,000 you can join Craig Venter and James Watson among the world’s first 20 people to have your genome sequenced. But what will you do with the information? Can your doctor read the AGCT code? Is a faulty gene sequence a “pre-existing condition” that your insurer won’t cover? Genomics promised a revolution in drug discovery productivity, but it didn’t happen and the pharma blockbuster business model is seriously ill. Can personalized, genetically discriminatory, drugs like Herceptin and Gleevec resurrect pharma? But getting FDA approval on a diagnostic and a drug will increase the cost of drug discovery. It seems like everyone loves personalized medicine as long as someone else is paying for it. Moderator:
Speakers include:
|
| 3:00 - 3:30 PM Ground Floor Lobby |
Coffee Break/Networking |
4:15 - 6:00 PM |
Web 2.0 Technologies and Healthcare Enterprise The session will update members about what is happening at the intersection of web 2.0 and healthcare. Information, appropriately gathered, analyzed and dispersed, will change the healthcare industry in ways we can only imagine. Kevin Green of Triple Tree, a boutique investment bank that specializes in healthcare and technology that has regular access to over 400 of the most influential players, will provide an overview of what is currently happening in the marketplace and where the industry is heading. David Cerino of Microsoft will share their strategy and how their health information ecosystem will impact the healthcare industry. Roy Schoenberg, MD, MPH, of American Well will discuss what providers are doing to connect themselves to each other, patients and payors. James Heywood of PatientsLikeMe will explain what patients are doing to take greater control over information that impacts their health and wellbeing. Kelly Victory, MD, former Chief Medical Officer at Whole Health, will moderate a lively panel discussion and facilitate audience participation HBS-style. This will be a rapid-fire session where a great deal of knowledge and information will be exchanged.
Moderator:
|
| 6:15 - 7:15 PM Ground Floor Lobby |
Cocktail Reception Drinks, Hors D'Oeuvres, Networking |
| 7:15 - 9:30 PM Elements Café |
9th Annual HBS Health Conference Dinner
|
Saturday, November 8 |
|
8:30 AM - 2:00 PM |
Badge Pick-Up (No onsite registration.) |
| 8:30 - 9:45 AM Rooms 214, 216, 217 and Second Floor Conference Lounge |
Roundtable Discussions
|
| 10:00 - 10:45 AM Amphitheater |
Medical Tourism and Telemedicine: Medical travel is no longer for cosmetic surgery and spas. An estimated half-million Americans seek medical care each year abroad. This is a thriving $60 billion global business, with a growth rate of 20 percent according to Lancet. US insurers can save considerably by reimbursing much lower expenses for elective procedures overseas.
|
| 10:45 - 11:15 AM Amphitheater |
Teleradiology: A Discipline That Pioneered the Digital Era of Telemedicine
The 21st century brought with it an alignment of the stars with respect to teleradiology. Widespread broadband capabilities in conjunction with shortages in the supply of radiologists and the need for improved efficiencies resulted in the formation of Nighthawk Radiology Services. Today, this publicly traded company, through its independently contracted radiologists and technologic infrastructure, provide nighttime and off-hours emergency radiology interpretations to greater than 1,500 hospitals (26 percent of all US hospitals). Connecting world-class subspecialty radiologists to these hospitals has led to improved quality, increased efficiency, and access to care otherwise largely unattainable. The growth of teleradiology will be chronicled with a discussion of the current status and future opportunities.
|
| 11:15 - 11:25 AM Ground Floor Lobby |
Break |
| 11:25 - 12:15 PM Amphitheater |
Medical Travel Panel Discussion
|
| 12:30 - 1:30 PM Elements Café |
Networking Lunch and "Mentor Meet" |
1:30-2:45 PM Amphitheater for Rapid-Fire Presentations 2:45-3:30 PM Rooms 214, 216, 217 and Second Floor Lounge for Breakout Sessions Refreshments served.
|
__________________________________________________________________ Co-hosted with the Harvard University Office of Technology Development Open to all, free to Conference attendees. Separate registration. Click here. Get a sneak preview of the top 10 new healthcare technology companies being spun out of Harvard University. Sirtris Pharmaceuticals, Infinity Pharmaceuticals and Curis are together worth over $1 billion. What do they all have in common? They are all spin-outs from Harvard University. At a special event immediately after the annual conference, you can get a sneak preview of the next generation companies coming out of Harvard University’s labs. These new technologies span pharmaceuticals, medical devices, diagnostics and life science instruments. They come from the labs of some of the greatest scientific entrepreneurs of our generation such as George Whitesides. Harvard University has transformed its intellectual property management from a simple licensing office to a full fledged technology and entrepreneur development operation complete with its own incubator fund and entrepreneurship bootcamp for faculty. These startup companies, all based on breakthrough technology developed in the labs at Harvard University, are seeking people like you to be investors, board members, advisors and strategic partners in the healthcare industry. This is a unique opportunity for HBS Health members to be the first to see the future technologies of healthcare, and who knows, maybe find the next billion dollar deal. Inventors and leaders in next-generation life sciences technologies will present five-minute overviews of opportunities. During break-out sessions, each group presenting will be available for more in-depth discussions, questions and networking.
|
 |
Note: Program is subject to change. |
©2008 Harvard Business School Health Industry Alumni Association.
